Effectiveness of Messages to Mobile Phone in Smoke Cessation
NCT ID: NCT01746069
Last Updated: 2015-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
320 participants
INTERVENTIONAL
2013-03-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main objective: To evaluate the effectiveness of a combined 6 months smoking cessation program including health advice provided by a doctor and sending support messages to mobile phone of patients.
Methods: Study design: Randomized single blind clinical trial. Study population: Patients over 18 who are willing to start a smoking cessation program, who have mobile phone, who are able to receive and send messages, and who have a score greater than 5 or equal to 5 on the Richmond scale.
Sample size: 160 patients per arm to detect a difference in the percentage of smoking cessation than 10% (14.9% vs. 4.9%) between the two groups. Intervention: Experimental group: Health advice and support messages to mobile phone patients.
Control group: Health advice. Assessment of the primary endpoint: At 6 months (positive/negative coximetry test).
Statistical analysis: The analysis of the primary endpoint (positive / negative coximetry test) will be performed using logistic regression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Text Messaging Program for Smokers in Primary Care
NCT03174158
Engagement With an Adaptive Mobile Health Smoking Cessation Intervention
NCT04020718
Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention
NCT02613689
Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers
NCT03096145
Mobile-based Peer Mentoring for Smoking Cessation
NCT03048786
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
health advice
clinical practice routine
health advice
routine clinical practice
Quit smoking combined cessation programme
Health advice and support sms messages to patient's mobile phone + clinical routine practice
Quit smoking combined cessation programme
Support sms messages to patient's mobile phone and health advice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quit smoking combined cessation programme
Support sms messages to patient's mobile phone and health advice
health advice
routine clinical practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current smoker (25): Current smoker is defined as the person who at the time of the study beginning declares that smoked daily or occasionally.
* Possessing mobile phone.
* Able to receive and send messages through mobile phone.
* Score greater than 5 or equal to 5 on the Richmond scale
Exclusion Criteria
* Patients with a diagnosis of depression using the depression subscale of Goldberg (two or more positive responses).
* Patients who with pharmacological therapy for smoking cessation or who require it throughout the study.
* Pregnant women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Basque Health Service
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raquel Cobos Campos
pharmaceutical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health centre Lakuabizkarra
Vitoria-Gasteiz, Alava, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.